CN103766909A - Novel food rich in omega-3 compounded food supplement - Google Patents
Novel food rich in omega-3 compounded food supplement Download PDFInfo
- Publication number
- CN103766909A CN103766909A CN201210395187.0A CN201210395187A CN103766909A CN 103766909 A CN103766909 A CN 103766909A CN 201210395187 A CN201210395187 A CN 201210395187A CN 103766909 A CN103766909 A CN 103766909A
- Authority
- CN
- China
- Prior art keywords
- omega
- parts
- food
- linoleic acid
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 17
- 235000020660 omega-3 fatty acid Nutrition 0.000 title abstract description 19
- 235000015872 dietary supplement Nutrition 0.000 title abstract description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 32
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 28
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 28
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 28
- 241000229143 Hippophae Species 0.000 claims abstract description 22
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 22
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 20
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 20
- 229940046009 vitamin E Drugs 0.000 claims abstract description 20
- 239000011709 vitamin E Substances 0.000 claims abstract description 20
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- 229930003944 flavone Natural products 0.000 claims abstract description 13
- 235000011949 flavones Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000015895 biscuits Nutrition 0.000 claims abstract description 6
- 235000008429 bread Nutrition 0.000 claims abstract description 6
- 235000012970 cakes Nutrition 0.000 claims abstract description 6
- 235000009508 confectionery Nutrition 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 21
- 235000010445 lecithin Nutrition 0.000 claims description 21
- 229940067606 lecithin Drugs 0.000 claims description 21
- 239000000787 lecithin Substances 0.000 claims description 21
- 150000002213 flavones Chemical class 0.000 claims description 11
- 235000014105 formulated food Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- 241000282414 Homo sapiens Species 0.000 abstract description 17
- 235000019197 fats Nutrition 0.000 abstract description 16
- 239000000463 material Substances 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract description 2
- 150000002212 flavone derivatives Chemical class 0.000 abstract description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 235000015816 nutrient absorption Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 125000001931 aliphatic group Chemical group 0.000 description 10
- 230000002265 prevention Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000004930 Fatty Liver Diseases 0.000 description 5
- 206010019708 Hepatic steatosis Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 208000010706 fatty liver disease Diseases 0.000 description 5
- 231100000240 steatosis hepatitis Toxicity 0.000 description 5
- 206010016654 Fibrosis Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 206010039966 Senile dementia Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 230000007882 cirrhosis Effects 0.000 description 4
- 208000019425 cirrhosis of liver Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000008157 edible vegetable oil Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- UCZJPQIEFFTIEV-UHFFFAOYSA-N 5-methoxy-6-methyl-2-phenylchromen-7-one Chemical compound C=1C=C2C(OC)=C(C)C(=O)C=C2OC=1C1=CC=CC=C1 UCZJPQIEFFTIEV-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000008162 cooking oil Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- -1 linoleic acid, leukotrienes Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000011305 Capsella bursa pastoris Nutrition 0.000 description 1
- 240000008867 Capsella bursa-pastoris Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000004481 Choline Deficiency Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 244000236527 Linum perenne Species 0.000 description 1
- 235000008569 Linum perenne Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical class C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000021752 choline deficiency disease Diseases 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019508 mustard seed Nutrition 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a novel food rich in omega-3 compounded food supplement. The food is composed of the following raw materials in parts by weight: 75 to 94 parts of plant omega-3 extract, wherein the omega-3 content is more than or equal to 55g/100g; 3 to 15 parts of sea-buckthorn seed extract, wherein the flavone content is more than or equal to 650mg/100g; 2 to 7 parts of phosphatidylcholine, wherein the linoleic acid content is less than or equal to 100mg/100g, and 1 to 5 parts of vitamin E, wherein the linoleic acid content is less than or equal to 100mg/100g. The food is prepared by the following steps: mixing the raw materials mentioned above, gently stirring the mixture at a room temperature in an atmosphere which meets the food sanitary standards, and then adding candies, bread, biscuits, or cakes to make into various novel foods. Omega-3 is taken as the main material (monarch), sea-buckthorn seed extract is taken as the auxiliary material (minister), thus more nutrients including omega-3 are provided for the human body; furthermore, phosphatidylcholine (assistant) and vitamin E (guide) are added, so the novel food provides fat and a more balanced formula for human body and promotes the nutrient absorption and utilization of human body.
Description
Technical field
The present invention relates to field of food, especially relate to a kind of novel foodstuff that is rich in omega 3 formulated food replenishers.
Background technology
Our three meals in a day be unable to do without grease, and it not only makes food fragrant U.S. good to eat, promotes appetite, the especially needed nutriment of human normal vital movement.Expanding economy makes people break away from the arduous age of purchasing oil with cooking oil coupon.On market, edible oil supply becomes increasingly abundant, and resident's consumption figure also increases greatly.But the consumption of too much grease brings problems to again people's health, impel scholars to further investigate grease and healthy relation.
Along with economic development and growth in the living standard, the heat that the animal fat of people's wedging discharges accounts for the ratio of gross energy, the higher limit 30% considerably beyond it having (being normally 20% to 30%).And these animals are made present stable breeding into by putting in a suitable place to breed of past, the feed difference of eating due to them, form fatty aliphatic acid in its animal body variation also occurred---be close to equally by original ω-6 family aliphatic acid and ω-3 family aliphatic acid, become and contain now too much ω-6 family aliphatic acid and extremely lack ω-3 family aliphatic acid.According to nutrition survey report both domestic and external, in the aliphatic acid of taking at people's diet, ω-6 family content of fatty acid has been more than 20 times of ω-3 family content of fatty acid.
Due to the raising of people's living standard, particularly the consumption abundant and cooking oil of compatriots' dish is more, according to foreign medical science man, only need to take in for each person every day the linoleic acid of 4 grams---be equivalent to the linoleic acid content in the soya-bean oil of half soup ladle, and in fact people every day along with the edible oil of dish wedging is considerably beyond 2-3 soup ladle.In addition current most edible oil only rests in the raising of purifying process (having accomplished that five is de-even six de-), but its chemical composition is not by enough attention.The linoleic acid that contains more ω-6 family in most edible oils, lacks and even extremely lacks ω-3 family and alpha-linolenic acid.
The result of comprehensive above two kinds of situations is, fat intake total in people's diet is too much, wherein exists again linoleic acid in aliphatic acid too much and the very few this ratio serious unbalance problem of alpha-linolenic acid.Grease intake is too much, except meeting causes obesity, also can cause hyperliposis in blood.When aliphatic acid is superfluous, by the mainly form storage with triglyceride, thereby cause Lipid increase, initiation diabetes, high fat of blood, hypertension, angiocardiopathy wait chronic disease.The fat content that children and teenager take in every day is too high, and in fat and blood, the easy formation of calcium ion is not easy the saponification calcium that is absorbed by health and utilize, thereby affects growing of bone.
But fat intake is very few also bad, there is considerable people one to mention fat and will associate the diseases such as obesity, coronary heart disease, breast cancer, think that fat is got fat people, cause no good.Have fat is used as is " arch-criminal " who causes the diseases such as human body cancer, cardiovascular disease and obesity.This viewpoint is extremely wrong, on the contrary health is had to potential harm.Appropriate fat, for human physiology and psychology, is all considerable.Especially cannot self synthetic essential fatty acid alpha-linolenic acid, gamma-Linolenic acid for human body, health is had to very important effect.Scientific research confirms, the modern diseases such as high fat of blood, diabetes, artery sclerosis, cancer, early ageing are all relevant with these essential fatty acids of shortage.Further research is found, takes in appropriate essential fatty acid, to preventing above disease, comprise reduce blood pressure, cholesterol and triglyceride content, prevention of arterial is atherosis, maintains hematoblastic normal function, has important value.In addition, they to anti-ageing, regulate immunologic function, resist skin disease and virus infections, protection student eyesight etc. also has positive role.
Summary of the invention
In order to solve modern humans, after the meats such as chicken that extensively edible suitability for industrialized production feed is fed, duck, pig, fish, the problem of existing disappearance omega 3 aliphatic acid.The invention provides a kind of novel foodstuff that is rich in omega 3 formulated food replenishers.
The present invention's excessive saturated fatty acid and dracorhodin thing (being deposit) in body of can effectively degrading, the harmful pathology materials of human body such as degraded low density cholesterol, high triglyceride, increase the component content of HDL-C and HDL, fundamentally effectively prevent and treat high fat of blood, fatty liver, miocardial infarction and hypertensive generation; Effectively suppress thrombosis and dissolve thrombus, reparation thrombus scar, the required blood oxygen of assurance blood vessel, recover blood vessel elasticity, to reach softening blood vessel, reduce blood pressure and blood sugar, suppress generation and the transfer of tumour, prevent arteriosclerotic effect.To improving teen-age memory and thinking ability, prevention senile dementia and reduction inflammation, the aspects such as the visual acuity of raising people's eyes, the effect that has other materials can not be substituted.
Main component of the present invention is: plant omega 3 extracts, seabuckthorn seeds extract, lecithin, vitamin E, its raw material are selected as: plant omega 3 extracts (ω-3 content for >=58g/100g) 75-94 part according to quality proportioning, seabuckthorn seeds extract (flavones content >=650mg/100g) 3-15 part, lecithin (linoleic acid≤100mg/100g) 2-7 part, vitamin E (linoleic acid≤100mg/100g) 1-5 part, under the normal temperature environment that meets food hygiene, evenly after soft stirring, can insert as candy, bread, biscuit, cake etc., make all kinds of novel foodstuffs.
Its raw material are selected as 75 parts of: plant omega 3 extracts (ω-3 content for >=55g/100g) according to quality proportioning, 15 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 5 parts, lecithin (linoleic acid≤100mg/100g), 5 parts of vitamin Es (linoleic acid≤100mg/100g).
Its raw material are selected as 94 parts of: plant omega 3 extracts (ω-3 content for >=55g/100g) according to quality proportioning, 3 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 2 parts, lecithin (linoleic acid≤100mg/100g), 1 part of vitamin E (linoleic acid≤100rag/100g).
Its raw material are selected as 85 parts of: plant omega 3 extracts ((I) one 3 content for >=55g/100g) according to quality proportioning, 10 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 4 parts, lecithin (linoleic acid≤100mg/100g); 1 part of vitamin E (linoleic acid≤100mg/100g).
Plant omega 3 extract basic function main manifestations are: can obviously improve teen-age memory and thinking ability, and have prevention senile dementia generation, prevention cardiovascular and cerebrovascular disease, reduction blood fat and blood pressure, suppress generation and the transfer of hemorrhagic cerebral apoplexy, thrombotic diseases, cancer, prevention human senility and allergic reaction, the effects such as prevention miocardial infarction and cerebral infarction, anaphylactia, anti-inflammatory.Adopt from wild flax shepherd's purse, purple perilla and originate in Canada and " Ke Luona " seed of NORTHWEST CHINA (also claiming mustard seed), the high concentration plant omega 3 (ω-3) extracting, have that technique is simple, technology maturation and stable, raw material is extensive, containing cholesterol, international, domestic market is on sale in a large number.
Seabuckthorn seeds extract (being mainly Seabuckthorm Seed Oil or fruit oil): adopt German CO2 means of supercritical extraction technology to quench and get.In sea-buckthorn, contain abundant vitamin (Ve, Ve, Vp, Vk, VB6, VBl2 etc.), carotenoid (beta carotene), unsaturated fatty acids (linoleic acid, leukotrienes, palmitic acid etc.), flavonoids (glycosides displayed, glycosides million, Isorhamnetin, Quercetin), trace element (Fe, Cu, Zn, K, Ca etc.) amino acid (17 kinds of necessary compositions of human body such as asparatate), organic acid (malic acid, oxalic acid etc.), phospholipid (lecithin, cephalin, phosphatidylinositols) and 5. hydroxytryptamines, spend blue or green rope in vain, cumarin etc.Seven kinds (not containing tryptophans) in eight seed amino acids that contain needed by human, the trace element that sea-buckthorn contains 11 kinds of needed by human such as calcium, iron, zinc, potassium, selenium.In every 100g Main Ingredients and Appearance, contain: general flavone (in Quercetin) 710mg; Total carotinoid >=150mg; Carrotene >=5mg; β vitamin E >=100mg: γ vitamin E >=60mg; Unsaturated fatty acid content >=65%; Wherein ω-3 insatiable hunger aliphatic acid >=28%; Unsaponifiable matter >=1%.
As far back as the Chinese Tibetan medicine and pharmacology classical works Four-Volume Medical Code, just recorded sea-buckthorn have eliminate the phlegm, sharp lung, dampness elimination, strong cloudy, rise positive function, more than 60 have located to record the effect of sea-buckthorn strengthening spleen and nourishing stomach, removing blood stasis and hemostasis.Today, more having been established by " Chinese pharmacopoeia " is the precious resources of medicine food double-purpose.Its anti-inflammatory myogenic, press down tumour, increase immune, anti-ageing, radioresistance, to the blood vessel of heart and brain, the system of stomach is effective in cure greatly.
Sea-buckthorn Seabuckthorm Seed Oil or fruit oil have significant curative effect to burn, scald and cervical erosion clinically; To chronic superficial gastritis, atrophic gastritis, gastric ulcer, duodenal ulcer, canker sore, weakness due to chronic disease, the senile determined curative effect such as weak; To cardiovascular and cerebrovascular diseases such as prevention and treatment coronary heart diseases and angina pectoris, artery sclerosis; Can play balanced nutritious, conditioning functions, the metabolic effect of adjusting to the different physiological system of human body, thereby human body is played to the effect of comprehensive health care, be described as tool of the mankind's Construction Technologies in Twenty-one Century nutrition and health care and the natural medicaments article of development prospect by international medicine and pharmacology and nutrition expert.Chinese Water Conservancy portion sea-buckthorn research center produces in a large number.
Lecithin is taken from soybean.Soybean is described as 21 century " vitamin ".Many health cares of the main component in soybean---lecithin are also familiar with by people gradually.In the U.S., state food NI is formally decided to be necessary nutrient every day choline, and lecithin is the best donor of choline, and supplementary lecithin just equals to have supplemented choline, and this is also why fashionable America and Europe's main cause of lecithin.In thousands of kinds of nutritious supplementary pharmaceuticals of the U.S., ranking list second (first is vitamins) is in the sale of lecithin, and it has become the nutrient equally important with protein, vitamin.
The function of its prevention fatty liver and cirrhosis is remarkable, and the choline in phosphatide has affinity to fat, if choline deficiency in body can affect fat metabolism, causes fat in liver inner accumulated, forms fatty liver cirrhosis even can occur.Lecithin not only can prevent fatty liver, can also promote liver cell regeneration, prevents cirrhosis, and contributes to the recovery of liver function, and the cirrhosis especially some being caused because of excessive drinking has obvious effect.
It can promote nerve conduction, improves brain vigor, reduces the circulation of serum cholesterol, reduction blood viscosity, promotion blood, angiocardiopathy preventing.Phosphatide has the cell activation of making, and makes the function of the activation of brain function and prevention senile dementia: intelligence development, the hypermnesia of phosphatide to people has unique effect.Phosphatide can, by the fatty emulsification of hoarding in liver, with the liver cell that adequately protects, promote hepatocellular activation and regeneration, strengthens liver function, and to preventing and treating hepatopathy, particularly fatty liver effect is remarkable.It is conventional healthcare items.
Vitamin E has another name called tocopherol or Vitamin E, and vitamin E is widely used in again anti-ageing aspect, thinks that it can eliminate the deposition of lipofuscin in cell, improves the normal function of cell, and histiocytic aging course slows down.Vitamin E has very strong antioxidation, can prevent that fatty compound, vitamin A, selenium (Se), two kinds of sulphur amino acid and ascorbic oxidation from doing and the effect of raising vitamin A.Vitamin E is a kind of very important vasodilator and anticoagulant, can delay cell aging because of oxidation, the looks that retain youth.Can supply with oxygen in body, make you more have endurance.Work with vitamin A one, resist atmosphere pollution, protection lungs, prevent blood clotting, and the effect such as lessen fatigue.It is conventional healthcare items.
The invention has the beneficial effects as follows: adopt in Traditional Chinese Medicine health theory; the method that monarch, minister, assistant make; carry out reasonable compound combination, protected the natural active matter of 4 kinds of different materials, given prominence to again the importance of supplementary omega 3 (ω-3).Wherein take omega 3 (ω-3) as (monarch), again take seabuckthorn seeds extract as (minister), make up lacking of some compositions in omega 3 (ω-3).In addition lecithin, for the consumption of (assistant) and the fore-telling take vitamin E as (making), makes this compound omega 3 food supplement again, has the supplementary of the more balanced fatty material of pair human body, has also strengthened absorption and the application of human body.Meanwhile, be of value to the storage of this compound long period.Therefore, increased this kind of compound in food processing process, the effect of extensive use.
The specific embodiment
Embodiment mono-
Get 75 parts of plant omega 3 extracts (ω-3 content is >=55g/100g), 15 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 5 parts, lecithin (linoleic acid≤100mg/100g), 5 parts of vitamin Es (linoleic acid≤100mg/100g), under the normal temperature environment that meets food hygiene, evenly, after soft stirring, can insert as candy, bread, biscuit, cake etc., make all kinds of novel foodstuffs.
Embodiment bis-
Get 94 parts of plant omega 3 extracts (ω-3 content is >=55g/100g), 3 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 2 parts, lecithin (linoleic acid≤100mg/100g), 1 part of vitamin E (linoleic acid≤100rag/100g), under the normal temperature environment that meets food hygiene, evenly, after soft stirring, can insert as candy, bread, biscuit, cake etc., make all kinds of novel foodstuffs.
Embodiment tri-
Get 85 parts of plant omega 3 extracts ((I) one 3 content are >=55g/100g), 10 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 4 parts, lecithin (linoleic acid≤100mg/100g); 1 part of vitamin E (linoleic acid≤100mg/100g), under the normal temperature environment that meets food hygiene, evenly, after soft stirring, can insert as candy, bread, biscuit, cake etc., makes all kinds of novel foodstuffs.
Claims (4)
1. one kind is rich in the novel foodstuff of omega 3 formulated food replenishers, main component is: plant omega 3 extracts, seabuckthorn seeds extract, lecithin, vitamin E, it is characterized in that raw material select as: plant omega 3 extracts (ω-3 content for >=55g/100g) 75-94 part according to quality proportioning, seabuckthorn seeds extract (flavones content >=650mg/100g) 3-15 part, lecithin (linoleic acid≤100mg/100g) 2-7 part, vitamin E (linoleic acid≤100mg/100g) 1-5 part, under the normal temperature environment that meets food hygiene, evenly after soft stirring, can insert as candy, bread, biscuit, cake etc., make all kinds of novel foodstuffs.
2. a kind of novel foodstuff that is rich in omega 3 formulated food replenishers according to claim 1, it is characterized in that described raw material can select as 75 parts of: plant omega 3 extracts (ω-3 content for >=55g/100g) according to quality proportioning, 15 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 5 parts, lecithin (linoleic acid≤100mg/100g), 5 parts of vitamin Es (linoleic acid≤100mg/100g).
3. a kind of novel foodstuff that is rich in omega 3 formulated food replenishers according to claim 1, it is characterized in that described raw material can select as 94 parts of: plant omega 3 extracts (ω-3 content for >=55g/100g) according to quality proportioning, 3 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 2 parts, lecithin (linoleic acid≤100mg/100g), 1 part of vitamin E (linoleic acid≤100rag/100g).
4. a kind of novel foodstuff that is rich in omega 3 formulated food replenishers according to claim 1, it is characterized in that described raw material can select as 85 parts of: plant omega 3 extracts ((I) one 3 content for >=55g/100g) according to quality proportioning, 10 parts of seabuckthorn seeds extracts (flavones content >=650mg/100g), 4 parts, lecithin (linoleic acid≤100mg/100g); 1 part of vitamin E (linoleic acid≤100mg/100g).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210395187.0A CN103766909A (en) | 2012-10-17 | 2012-10-17 | Novel food rich in omega-3 compounded food supplement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210395187.0A CN103766909A (en) | 2012-10-17 | 2012-10-17 | Novel food rich in omega-3 compounded food supplement |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103766909A true CN103766909A (en) | 2014-05-07 |
Family
ID=50560032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210395187.0A Pending CN103766909A (en) | 2012-10-17 | 2012-10-17 | Novel food rich in omega-3 compounded food supplement |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103766909A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104799298A (en) * | 2015-05-20 | 2015-07-29 | 曾晓飞 | Nutrition supplementing liquid combining astaxanthin and omega 3 |
CN104856055A (en) * | 2015-05-20 | 2015-08-26 | 曾晓飞 | Food supplement with combination of astaxanthin and omega-3 |
CN105962373A (en) * | 2016-05-17 | 2016-09-28 | 单克定 | Omega 3-containing health food and preparation method thereof |
CN112293737A (en) * | 2020-12-01 | 2021-02-02 | 曾晓飞 | Omega 3 and phillyrin combined plant antiviral and anti-inflammatory food supplement |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496585A (en) * | 2008-01-31 | 2009-08-05 | 郑善良 | Omega 3 complex food supplement |
CN101554190A (en) * | 2008-04-09 | 2009-10-14 | 新疆医科大学 | Edible oil containing two types of essential fatty acid |
KR100930266B1 (en) * | 2008-09-03 | 2009-12-09 | 신봉석 | Water-soluble linseed oil-containing food additive composition for preparing bean sprouts containing omega-3 fatty acid |
-
2012
- 2012-10-17 CN CN201210395187.0A patent/CN103766909A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496585A (en) * | 2008-01-31 | 2009-08-05 | 郑善良 | Omega 3 complex food supplement |
CN101554190A (en) * | 2008-04-09 | 2009-10-14 | 新疆医科大学 | Edible oil containing two types of essential fatty acid |
KR100930266B1 (en) * | 2008-09-03 | 2009-12-09 | 신봉석 | Water-soluble linseed oil-containing food additive composition for preparing bean sprouts containing omega-3 fatty acid |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104799298A (en) * | 2015-05-20 | 2015-07-29 | 曾晓飞 | Nutrition supplementing liquid combining astaxanthin and omega 3 |
CN104856055A (en) * | 2015-05-20 | 2015-08-26 | 曾晓飞 | Food supplement with combination of astaxanthin and omega-3 |
CN105962373A (en) * | 2016-05-17 | 2016-09-28 | 单克定 | Omega 3-containing health food and preparation method thereof |
CN112293737A (en) * | 2020-12-01 | 2021-02-02 | 曾晓飞 | Omega 3 and phillyrin combined plant antiviral and anti-inflammatory food supplement |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Balch | Prescription for nutritional healing | |
CA2715261C (en) | Food products containing omega-3 fatty acids | |
JP2004515508A (en) | COMPOUND HEALTH PROMOTING COMPOSITION | |
CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
CN102389053A (en) | Production method of eggs with low cholesterol, abundant selenium and abundant carotene | |
CN106720460A (en) | Edible oil | |
CN101028335A (en) | Walnut oil health-care soft capsule | |
CN103766909A (en) | Novel food rich in omega-3 compounded food supplement | |
CN101496585B (en) | Omega-3 composite foodstuffs replenisher | |
KR20170013688A (en) | The onion juice and method of it | |
JP5199241B2 (en) | Nutritional supplement and method for producing the same | |
Yannakopoulos | Egg enrichment in omega-3 fatty acids | |
CN103750311A (en) | Walnut/red date buccal tablet | |
Lee | Essent ial Fat ty Acids | |
CN105580983A (en) | Production method of low-cholesterol-content EPA-enriched eggs | |
KR101529301B1 (en) | Configure the chicken and roast octopus and method of manufacturing the nutritional | |
CN103766507A (en) | Edible oil with health-care function | |
CN102232538A (en) | Mushroom sauce and preparation method | |
Kanojia | Development of value-added cookies incorporated with Spirulina platensis for the mitigation of malnutrition in children | |
CN106819223A (en) | A kind of health-care milk tea and preparation method thereof | |
CN103005308B (en) | Spicy soybeans | |
CN105901170A (en) | Stomach-strengthening antioxidant sesame oil and a preparing method thereof | |
CN103393010A (en) | Chinese yam porridge with chicken cream and preparation method thereof | |
CN103652526A (en) | Prune jam and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Zeng Xiaofei Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |